Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Trask

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
The Laryngoscope|August 2, 2002
Expression of Bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: correlation with response to chemotherapy and organ preservationDouglas K Trask, Gregory T Wolf, Carol R Bradford, et al.
Cancer|July 10, 2001
National survey of head and neck verrucous carcinoma: patterns of presentation, care, and outcomeB B Koch, D K Trask, H T Hoffman, et al.
Cancer Biology & Therapy|December 19, 2006
Differential activity of sulindac metabolites against squamous cell carcinoma of the head and neck is mediated by p21waf1/cip1 induction and cell cycle inhibitionJonathan M Bock, Sarita G Menon, Prabhat C Goswami, et al.
Molecular Carcinogenesis|April 7, 2007
Relative non-steroidal anti-inflammatory drug (NSAID) antiproliferative activity is mediated through p21-induced G1 arrest and E2F inhibitionJonathan M Bock, Sarita G Menon, Prabhat C Goswami, et al.
Cancer Research|April 19, 2007
Celecoxib toxicity is cell cycle phase specificJonathan M Bock, Sarita G Menon, Lori L Sinclair, et al.
Ophthalmology|October 1, 1998
Silicone oil in the repair of complex retinal detachments. A prospective observational multicenter studyS P Azen, I U Scott, H W Flynn, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|May 1, 1990
Resorptive clearance and transepithelial potential difference in capsaicin-treated F344 ratsG T De Sanctis, E M App, J K Trask, et al.
Molecular Cancer Therapeutics|July 16, 2005
Reversal of cisplatin resistance with a BH3 mimetic, (-)-gossypol, in head and neck cancer cells: role of wild-type p53 and Bcl-xLJoshua A Bauer, Douglas K Trask, Bhavna Kumar, et al.
Archives of Otolaryngology--Head & Neck Surgery|March 17, 2004
Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinomaCecelia E Schmalbach, Douglas B Chepeha, Thomas J Giordano, et al.
Archives of Otolaryngology--Head & Neck Surgery|October 19, 2005
Long-term quality of life for surgical and nonsurgical treatment of head and neck cancerMark El-Deiry, Gerry F Funk, Sarvi Nalwa, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
The Laryngoscope|August 2, 2002
Expression of Bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: correlation with response to chemotherapy and organ preservationDouglas K Trask, Gregory T Wolf, Carol R Bradford, et al.
Cancer|July 10, 2001
National survey of head and neck verrucous carcinoma: patterns of presentation, care, and outcomeB B Koch, D K Trask, H T Hoffman, et al.
Cancer Biology & Therapy|December 19, 2006
Differential activity of sulindac metabolites against squamous cell carcinoma of the head and neck is mediated by p21waf1/cip1 induction and cell cycle inhibitionJonathan M Bock, Sarita G Menon, Prabhat C Goswami, et al.
Molecular Carcinogenesis|April 7, 2007
Relative non-steroidal anti-inflammatory drug (NSAID) antiproliferative activity is mediated through p21-induced G1 arrest and E2F inhibitionJonathan M Bock, Sarita G Menon, Prabhat C Goswami, et al.
Cancer Research|April 19, 2007
Celecoxib toxicity is cell cycle phase specificJonathan M Bock, Sarita G Menon, Lori L Sinclair, et al.
Ophthalmology|October 1, 1998
Silicone oil in the repair of complex retinal detachments. A prospective observational multicenter studyS P Azen, I U Scott, H W Flynn, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|May 1, 1990
Resorptive clearance and transepithelial potential difference in capsaicin-treated F344 ratsG T De Sanctis, E M App, J K Trask, et al.
Molecular Cancer Therapeutics|July 16, 2005
Reversal of cisplatin resistance with a BH3 mimetic, (-)-gossypol, in head and neck cancer cells: role of wild-type p53 and Bcl-xLJoshua A Bauer, Douglas K Trask, Bhavna Kumar, et al.
Archives of Otolaryngology--Head & Neck Surgery|March 17, 2004
Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinomaCecelia E Schmalbach, Douglas B Chepeha, Thomas J Giordano, et al.
Archives of Otolaryngology--Head & Neck Surgery|October 19, 2005
Long-term quality of life for surgical and nonsurgical treatment of head and neck cancerMark El-Deiry, Gerry F Funk, Sarvi Nalwa, et al.
Pageof 4